Biotechnology industry in Italy
Biotechnology industry in Italy is a highly innovative and fast growing sector dedicated to research. At the end of 2019, there are 696 biotech companies active in Italy.[1]
Industry
The turnover exceeds 12 billion euros, the number of employees exceeds 13,000 units. Between 2017 and 2019, over 50 new innovative start-ups active in biotechnology were registered.[2]
Healthcare
Vaccine
- The first Ebola vaccine in the world was developed in the IRBM Science Park laboratories, Pomezia, Rome, Italy.[3]
In the laboratories of the IRBM Science Park a team of Italian and American researchers has developed the Chad3Ebola-Zaire anti-ebola vaccine, a monovalent adenovirus capable of neutralizing the «Zaire» strain of the virus, conceived and produced by OKAIROS, a biotech company founded by Prof. Riccardo Cortese, with whom IRBM set up the Advent equal joint venture.
- A COVID-19 vaccine was developed in the IRBM Science Park laboratories, Pomezia, Rome, Italy, in cooperation with Jenner Institute Oxford University.[4][5][6]
An other COVID-19 vaccine was developed by ReiThera, Castel Romano, Rome, Italy, in cooperation with Spallanzani Hospital.[7]
Agricultural biotechnology
Research
The research intensity of the biotech sector is significantly higher than that found for the Italian industry as a whole.[8]
Organizations
Ministries
- Ministero della Salute
- Ministero delle Politiche Agricole Alimentari e Forestali (MiPAAF)
- Ministero dell'istruzione, dell'università e della ricerca (MIUR)
Agencies
Science parks and incubators
- Istituto di Ricerca di Biologia Molecolare P. Angeletti SpA (IRBM)
- IRBM Science Park
See also
References
- ^ "La fotografia delle imprese di biotecnologie in Italia". assobiotec.federchimica.it. assobiotec.federchimica.it. Retrieved 3 August 2020.
- ^ "La fotografia delle imprese di biotecnologie in Italia". assobiotec.federchimica.it. assobiotec.federchimica.it. Retrieved 3 August 2020.
- ^ "Ebola, con il vaccino sviluppato in italia si ottiene l'immunità per 10 mesi". La Repubblica. 7 September 2014. Retrieved 26 November 2015.
- ^ "Vaccino Oxford-Pomezia, a settembre 400 milioni di dosi: accordo con multinazionale Astrazeneca. Fondi anche dagli Usa". ilmessaggero.it. ilmessaggero.it. Retrieved 3 August 2020.
- ^ "The Jenner Institute signs an agreement with Advent to develop a novel coronavirus vaccine". IRBM.
- ^ "Vaccino Covid-19, sprint di azienda italiana: a fine aprile i test sull'uomo". ilsole24ore.com. ilsole24ore.com. 13 April 2020. Retrieved 3 August 2020.
- ^ "Vaccino italiano, via ai test sull'uomo allo Spallanzani". ilsecoloxix.it. ilsecoloxix.it. 7 August 2020. Retrieved 8 August 2020.
- ^ "La fotografia delle imprese di biotecnologie in Italia". assobiotec.federchimica.it. assobiotec.federchimica.it. Retrieved 3 August 2020.
External links
 | This Italy-related article is a stub. You can help Wikipedia by expanding it. |